⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL366786 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL3807937 | 0.72 | — | — | |
| SCHEMBL9282872 | 0.70 | — | — | |
| Sulfuric Acid SCHEMBL2591383 | 0.69 | LMNA (0.31) | — | |
| Sulfuric Acid SCHEMBL14958537 | 0.69 | LMNA (0.31) | — | |
| SCHEMBL30185 | 0.67 | — | — | |
| SCHEMBL7125516 | 0.67 | MAPT (0.38) | — | |
| Acetic Acid SCHEMBL8953872 | 0.67 | TSHR (0.35) | — | |
| SCHEMBL8677916 | 0.67 | — | — | |
| SCHEMBL15018926 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050113539-A1 | Crosslinked, water insoluble matrix; electrophoresis membranes | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2005-05-26 | — | — | US | claimed |
| WO-2003055923-A1 | NOVEL MONOMERS USEFUL IN THE PREPARATION OF SEPARATION MATRICES | AMERSHAM BIOSCIENCES AB (SE) | 2003-07-10 | — | — | WO | claimed |
| US-7060776-B2 | Monomers useful in the preparation of separation matrices | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2006-06-13 | — | — | US | disclosed |
| US-20050113539-A1 | Crosslinked, water insoluble matrix; electrophoresis membranes | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2005-05-26 | — | — | US | disclosed |
| WO-2003055923-A1 | NOVEL MONOMERS USEFUL IN THE PREPARATION OF SEPARATION MATRICES | AMERSHAM BIOSCIENCES AB (SE) | 2003-07-10 | — | — | WO | disclosed |